EPIGLOTTIC CANCER

EPIGLOTTIC CANCER was reported 32 times

EPIGLOTTIC CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-12 Antagonist [EPC] 2 0.0000
1 Interleukin-23 Antagonist [EPC] 2 0.0000
2 Aminosalicylate [EPC] 1 0.0000
3 Antirheumatic Agent [EPC] 1 0.0000
4 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
6 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 1 0.0000